Canngea exists to bridge the gap between ancient and contemporary medicine for a better quality of life.
We are an Australian medical cannabis contract manufacturing organisation (CMO), using proven technology to make consistent high-quality products at competitive prices.
Our Co-Founder, Ryan Ballantyne and Science Director, Dr Nial Wheate, share the story behind Canngea, and illuminate the solution it provides to the gap in the medicinal market.
Our vision is to be the leading medical cannabis manufacturer in Australasia. We will do this by utilising industry-leading technology, ensuring the highest quality pharmaceutical and nutraceutical products can consistently be produced at the lowest production cost.
